Simpson Thacher represented Certara, Inc. (“Certara”) and an entity affiliated with EQT AB (“EQT”) in connection with a secondary offering of common stock of Certara by EQT and other selling stockholders. The offering of 7,000,000 shares of Certara’s common stock raised approximately $124 million in gross proceeds, with the selling stockholders receiving all of the proceeds from the offering.
Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
The Simpson Thacher team included Bill Brentani, Kelli Schultz, Jonathan Kachiu, Laura Yang and Margaret Whalen (Capital Markets); and Jonathan Goldstein and Jonathan Cantor (Tax).